What Is New in Breast Cancer Treatment and Research?

Researchers worldwide are working to find better ways to prevent, diagnose and treat breast cancer and improve patients’ quality of life.
Some Active Areas of Breast Cancer Research Include:
- Causes of breast cancer
- Causes and treatment of metastatic breast cancer
- Reducing breast cancer risk
- How ductal carcinoma in situ (DCIS) should be treated
- New laboratory tests for breast cancer
- New imaging tests for breast cancer
- Breast cancer treatment
- Palliative care
Causes of Breast Cancer
Studies continue to reveal how lifestyle factors, habits and inherited breast cancer genes affect breast cancer risk. Some examples:
- Some studies focus on the effects of exercise, weight gain or loss, and different diets on breast cancer risk.
- In breast cancer, identifying the mutations that trigger cancer remains the subject of active research into the best use of genetic testing.
- Other changes do not constitute mutations but affect gene expression; these are called gene variations . Scientists are investigating how gene variations can affect breast cancer risk. These variations generally have a moderate effect on risk, but together may have a large effect.
- Environmental causes significantly affecting breast cancer have also attracted attention in recent years. Although most scientific research on this subject is at its earliest stages, it remains an active field.
- High-priority chemicals that may cause breast cancer identified
Reducing Breast Cancer Risk
Researchers continue investigating drugs to reduce breast cancer risk, particularly in studies that may help high-risk women.
- Hormonal therapy drugs generally help treat breast cancer, and some may also help prevent it. Tamoxifen and raloxifene have been used for years to prevent breast cancer in people with hereditary breast cancer risk. New studies of another hormonal drug class, aromatase inhibitors (exemestane and anastrozole), show these drugs are also effective in preventing breast cancer in high-risk people. However, hormonal treatments requiring long-term use have side effects and are certainly not recommended for all women. They are recommended following genetic counseling for people with extensive family histories of breast cancer and inherited cancer genes.
- Who should have genetic testing for hereditary breast cancer?
- Other clinical trials seek nonhormonal drugs to reduce breast cancer risk. Drugs investigated include those for osteoporosis and bone metastases , COX-2 inhibitors, nonsteroidal anti-inflammatory drugs and statins (used to lower cholesterol).
Bones are frequent sites of metastasis for breast cancer cells. Drugs such as bisphosphonates and denosumab are used to treat breast cancer that has metastasized to bone. Research also suggests these drugs might help prevent bone metastasis from breast cancer. However, further research is needed before recommending these bone-modifying drugs in early-stage breast cancer.
Where Are We in DCIS Treatment?
Ductal carcinoma in situ (DCIS) is the beginning of abnormal changes in cells lining the breast’s milk ducts and is a very early stage of breast cancer. Cancer cells are confined to the milk ducts and have not spread into the breast.
The main treatment for DCIS is surgery, removing the tumor with some surrounding normal tissue. However, the ideal treatment for DCIS remains unclear, because low-grade DCIS appears amenable to monitoring without surgery.
Uncertainty about how DCIS will behave can make selecting optimal treatment difficult. Researchers are investigating computer-based and statistical methods to predict the risk of a woman’s DCIS becoming conventional breast cancer. They ask women with DCIS which factors they consider important in choosing treatment and which help them decide, such as survival, preventing recurrence and side effects.
New Laboratory Tests
Liquid biopsy – tests for circulating tumor cells
Research shows that in many women with breast cancer, cells may break away from the tumor and enter the blood. Detecting circulating tumor cells and cell fragments, particularly cancer cell DNA, using sensitive laboratory tests is one of the most discussed topics in cancer medicine in recent years. Although these tests may help predict who could have metastatic breast cancer, it remains unclear whether they can predict recurrence after treatment, help patients or extend survival. Some studies investigate collecting these circulating tumor cells and testing them in the laboratory to determine which available chemotherapies work against the tumor (chemotherapy sensitivity tests).
New Imaging Tests (Radiological Methods)
Newer imaging methods are being studied to assess breast changes that could be cancerous.
Scintimammography (molecular breast imaging)
In this method, a low-radioactivity tracking agent is injected into a vein. Tracer is the name of this tracking agent, which binds to breast cancer cells and is detected with a special camera.
Studies continue to determine whether this technique will help diagnose breast cancer. Some doctors believe molecular imaging may confirm suspicious areas found on mammography, but its precise role remains unclear. Research aims to improve this technology and evaluate its use in women with dense breasts or younger women.
Breast Cancer Treatment
Chemotherapy
Chemotherapy benefits many breast cancer patients. However, researchers are still studying who benefits most or least. Chemotherapy can sometimes have significant side effects (long- and short-term), so tests identifying who needs chemotherapy may be useful. Many studies investigate different assessment tests that could determine which patients benefit from chemotherapy and which should avoid it.
Oncoplastic Surgery
Breast-conserving surgery (lumpectomy or partial mastectomy) is commonly used in early-stage breast cancer. However, if the tumor is large or the breast small, breast conservation may not be possible and removal of the whole breast (mastectomy) may be necessary. Breast reconstruction after breast-conserving surgery or complete reconstruction after mastectomy is increasingly performed by experienced breast cancer centers. Plastic surgeons have thus become routine members of the breast cancer treatment team.
Triple-Negative Breast Cancer
Triple-negative breast cancer cannot be treated with hormonal therapy or targeted treatment such as HER2 drugs, so treatment options are limited to chemotherapy. In recent years, other potential targets for new breast cancer drugs have been identified. Drugs directed at these targets, such as kinase inhibitors and immunotherapy , are being investigated in combinations or with chemotherapy to treat triple-negative breast cancer.
Targeted Drugs
Drugs directed at cancer-related molecular targets at the cellular level—for example, overabundant growth receptors —target genetic changes in cancer cells that help them grow or spread. New targeted therapies, including PARP inhibitors, are being studied against breast cancer. These drugs have shown likely benefit in cancers caused by BRCA gene mutations and may work in some breast cancer types. For example, olaparib (Lynparza) received FDA approval to treat women with metastatic, HER2-negative, BRCA mutation-positive breast cancer who previously received chemotherapy. Studies of other PARP inhibitors continue.
Palliative Care
Studies are seeking drugs to improve memory and cognitive function after chemotherapy. Others are assessing whether certain heart medications called beta-blockers can prevent heart damage caused by doxorubicin and epirubicin, chemotherapy drugs widely used in breast cancer.
Considering Joining a Clinical Trial
Clinical trials are controlled studies examining promising new treatments or procedures more closely; all new cancer treatments are products of these studies. Trials provide valuable information not only about new treatments, but also better side-effect management, early detection and cancer prevention. However, they are not suitable for everyone.
If you would like to learn about clinical trials that may be suitable for you, consult your doctor.
You May Be Interested:
Sources
American Cancer Society website cancer.org - Last Revised: February 1, 2018
Was this article helpful?
Your feedback helps us improve our content.





Reader comments
Share your comment
Your name and comment are published only after administrator approval. Your email address is never shown to visitors.
Be the first to comment.